The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride), for the treatment of schizophrenia, a chronic mental health disorder. Developed by Karuna Therapeutics and now owned by Bristol Myers Squibb, Cobenfy works by targeting cholinergic receptors unlike traditional antipsychotic medications that target dopamine receptors. This marks a significant departure from the conventional approach to schizophrenia treatment, according ...

A potential new treatment combining natural manuka honey with a widely used drug has been developed by scientists at Aston University to treat a potentially lethal lung infection and greatly reduce side effects of one of the current drugs used for its treatment. Manuka honey can also be used to help treat wounds, injuries, improve oral health, soothe a sore ...

In a paper published in the journal of Ocular Immunology and Inflammation, physicians from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine reported that several patients using germicidal lamps in an attempt to sanitize against the coronavirus, developed painful inflammation of the cornea, a condition called photokeratitis. These consumer-available ultraviolet (UV) emitting devices were being ...

Antiepileptic drugs may increase the risk of stroke among persons with Alzheimer’s disease, said a new study from the University of Eastern Finland. The risk remains the same whether the drugs are old or new antiepileptic drugs, said the study published in the Journal of the American Heart Association. The study, conducted at the University of Eastern Finland and funded ...

A key ingredient of energy drinks could be exacerbating some of the negative effects of binge drinking, said a new study sending a warning to many people who mix energy drinks with alcohol to counteract the sedative nature of alcohol, tricking users into feeling more awake and less drunk than they really are. Researchers from the University of Portsmouth and the ...

A new study by University of Sydney has found that excessive use of medication increases dementia, particularly unnecessary or inappropriate medications. Nearly 2,500 people were examined for the study conducted in collaboration with Yale University and University of Kentucky. The number of people living with dementia around the world is 50 million. In Australia alone, it is currently 425,000, which ...